An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Repare Therapeutics to Participate in Two Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Repare Therapeutics Inc. announced that its senior management team will participate in two investor conferences in November. The first conference is the Stifel 2023 Healthcare Conference on November 14th at 8:35 a.m. Eastern Time in New York, NY. The second conference is the Piper Sandler 35th Annual Healthcare Conference on November 28th at 10:30 a.m. Eastern Time, also in New York, NY. The fireside chats will be webcasted live on the company's website, with a replay available for at least 30 days.
Positive
None.
Negative
None.
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate at two investor conferences in November. Details for the fireside chats are as follows:
Stifel 2023 Healthcare Conference
Date: Tuesday, November 14, 2023
Time: 8:35 a.m. Eastern Time
Location: New York, NY
Piper Sandler 35th Annual Healthcare Conference
Date: Tuesday, November 28, 2023
Time: 10:30 a.m. Eastern Time
Location: New York, NY
A live webcast of the fireside chats can be accessed in the Investor section of the Company’s website at https://ir.reparerx.com/news-and-events/events. A replay of the webcast will be archived on the Company’s website for at least 30 days.
About Repare Therapeutics, Inc.
Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes lunresertib (also known as RP-6306), a PKMYT1 inhibitor currently in Phase 1 clinical development; camonsertib (also known as RP-3500 or RG6526), a potential leading ATR inhibitor currently in Phase 1/2 clinical development and partnered with Roche; RP-3467, a preclinical Polθ inhibitor program; as well as several additional, undisclosed preclinical programs, including RP-1664. For more information, please visit reparerx.com and follow @Reparerx on X (formerly Twitter) and LinkedIn.
SNIPRx® is a registered trademark of Repare Therapeutics Inc.
When and where will Repare Therapeutics participate in investor conferences in November 2023?
Repare Therapeutics will participate in two investor conferences in November 2023. The first conference is the Stifel 2023 Healthcare Conference on November 14th at 8:35 a.m. Eastern Time in New York, NY. The second conference is the Piper Sandler 35th Annual Healthcare Conference on November 28th at 10:30 a.m. Eastern Time, also in New York, NY.
How can I access the live webcast of the fireside chats?
The live webcast of the fireside chats can be accessed in the Investor section of Repare Therapeutics' website at https://ir.reparerx.com/news-and-events/events.
Will there be a replay of the webcast available?
Yes, a replay of the webcast will be archived on Repare Therapeutics' website for at least 30 days.
